A team of researchers has created the very first gene-edited dogs using a cloning process that involves skin cells. South Korean biotech company ToolGen, along with Chungnam National University, ...
While the traditional cloning workflow has been used in laboratories for decades, new techniques have emerged that allow for rapid assembly of multiple genetic fragments. The Electra Vector System, ...
April 12 (Reuters) - Vertex Pharmaceuticals Inc (VRTX.O), opens new tab and CRISPR Therapeutics AG's (CRSP.BN), opens new tab one-dose gene editing therapy for sickle cell disease would be cost ...
With the gold rush in obesity meds showing no sign of abating, Fractyl Health is gearing up to go public as it gathers preclinical evidence that its GLP-1 gene therapy could take on Novo Nordisk’s ...
FLT180a (verbrinacogene setparvovec) is a liver-directed adeno-associated virus (AAV) gene therapy that uses a synthetic capsid and a gain-of-function protein to normalize factor IX levels in patients ...
Enrolment in a trial investigating a novel gene editing therapy in patients with heterozygous familial hypercholesterolemia (HeFH) has been paused after laboratory abnormalities, including a grade 3 ...
(Bloomberg) -- One of the world’s most expensive medicines will be used to treat some patients with sickle cell disease in England using the state-funded National Health Service. The one-time ...
Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long-term growth.
AUSTIN, Texas, Aug. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback